Herc Holdings Inc. (HRI) Forms $65.06 Double Top; Quest Diagnostics (DGX) Had 8 Analysts Last Week

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 8 have Buy rating, 2 Sell and 11 Hold. Therefore 38% are positive. Quest Diagnostics had 66 analyst reports since August 4, 2015 according to SRatingsIntel. Goldman Sachs reinitiated the shares of DGX in report on Monday, January 29 with “Buy” rating. The stock has “Market Perform” rating by Wells Fargo on Friday, October 16. The firm has “Hold” rating by Zacks given on Tuesday, August 18. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Market Perform” rating given on Friday, October 20 by Wells Fargo. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, January 16 report. Canaccord Genuity maintained Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday, October 17 with “Buy” rating. As per Monday, November 14, the company rating was upgraded by UBS. The rating was maintained by FBR Capital with “Outperform” on Wednesday, April 12. The rating was upgraded by Credit Suisse to “Buy” on Tuesday, February 13. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Buy” rating given on Tuesday, July 25 by Canaccord Genuity. See Quest Diagnostics Incorporated (NYSE:DGX) latest ratings:

13/02/2018 Broker: Credit Suisse Rating: Buy New Target: $118.0 Upgrade
02/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $113.0 Maintain
02/02/2018 Broker: Credit Suisse Rating: Hold New Target: $107.0 Initiate
01/02/2018 Broker: SunTrust Rating: Hold New Target: $110.0 Maintain
01/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $106.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Hold New Target: $110.0 Maintain
29/01/2018 Broker: Goldman Sachs Old Rating: Buy New Rating: Buy New Target: $117 Reinitiate
24/01/2018 Broker: Mizuho Rating: Buy New Target: $113.0 Maintain
16/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $110.0 Maintain
05/01/2018 Broker: Evercore Rating: In-Line New Target: $103 Initiates Coverage On

Herc Holdings Inc. (HRI) formed double top with $69.61 target or 7.00% above today’s $65.06 share price. Herc Holdings Inc. (HRI) has $1.85B valuation. The stock decreased 0.23% or $0.15 during the last trading session, reaching $65.06. About 38,987 shares traded. Herc Holdings Inc. (NYSE:HRI) has risen 37.78% since March 1, 2017 and is uptrending. It has outperformed by 21.08% the S&P500.

Among 5 analysts covering Herc Holdings Inc. Common Stock (NYSE:HRI), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Herc Holdings Inc. Common Stock has $60.0 highest and $44 lowest target. $52’s average target is -20.07% below currents $65.06 stock price. Herc Holdings Inc. Common Stock had 11 analyst reports since July 6, 2016 according to SRatingsIntel. The firm has “Buy” rating by Northcoast given on Monday, December 5. On Thursday, September 21 the stock rating was maintained by Jefferies with “Hold”. Northcoast downgraded Herc Holdings Inc. (NYSE:HRI) on Tuesday, December 19 to “Neutral” rating. The firm has “Overweight” rating by KeyBanc Capital Markets given on Monday, April 10. The rating was upgraded by Northcoast to “Buy” on Friday, April 7. The company was initiated on Tuesday, November 29 by Jefferies. KeyBanc Capital Markets maintained the stock with “Buy” rating in Tuesday, September 12 report. On Tuesday, April 11 the stock rating was upgraded by KeyCorp to “Overweight”. The stock has “Neutral” rating by Goldman Sachs on Friday, December 9. The firm earned “Neutral” rating on Tuesday, February 7 by Northcoast.

Since September 5, 2017, it had 0 buys, and 10 insider sales for $31.67 million activity. RUSCKOWSKI STEPHEN H sold $272,768 worth of stock. $119,932 worth of stock was sold by Klug Robert A on Friday, February 23. The insider STANZIONE DANIEL sold $4.42 million. Shares for $2.21 million were sold by Doherty Catherine T. on Wednesday, January 24. Another trade for 63,880 shares valued at $6.30 million was sold by Davis J. E..

The stock decreased 0.34% or $0.35 during the last trading session, reaching $102.7. About 72,048 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has risen 39.04% since March 1, 2017 and is uptrending. It has outperformed by 22.34% the S&P500.

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company has market cap of $13.93 billion. The companyÂ’s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. It has a 18.67 P/E ratio. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.01, from 0.99 in 2017Q2. It worsened, as 51 investors sold Quest Diagnostics Incorporated shares while 184 reduced holdings. 57 funds opened positions while 173 raised stakes. 116.90 million shares or 2.64% more from 113.89 million shares in 2017Q2 were reported. Advsr Asset holds 0.06% or 40,216 shares in its portfolio. 4,600 were reported by Compton Cap Ri. Rand Wealth Ltd Com owns 18,223 shares or 0.2% of their US portfolio. Liberty Mutual Asset Mngmt Inc holds 5,741 shares. Numeric Investors Ltd Liability Company holds 10,200 shares or 0.01% of its portfolio. Comml Bank Of America De owns 2.17 million shares. Advantage holds 2.31% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX) for 30,351 shares. Federated Invsts Pa holds 0.08% or 292,499 shares. Cap Intll Invsts reported 1.30M shares. First Wilshire Securities Management Inc owns 2,450 shares for 0.06% of their portfolio. Motley Fool Wealth Limited Com reported 2,689 shares or 0.02% of all its holdings. 25,753 are held by Philadelphia Tru Communications. Veritas Mngmt Llp invested 0.02% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Atria Ltd Company stated it has 0.05% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Credit Agricole S A has 133,310 shares.